Consensus DexCom, Inc. Sao Paulo

Stocks

D1EX34

BRD1EXBDR004

Medical Equipment, Supplies & Distribution

Delayed Sao Paulo 01:15:55 04/09/2026 am IST			5-day change	1st Jan Change
9.170 ^BRL	-1.50%		-1.19%	+22.43%

25/08	Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing	MT
13/08	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT

Evolution of the Average Target: DexCom, Inc.

Evolution of the Target Price: DexCom, Inc.

Changes in Analyst Recommendations: DexCom, Inc.

ac53.4wc2fa3DGjp9MJt2a6jDhODVgfCTvYuNgq5ZOtUm0gI.0ExMOd-1N3AXaNAUKeKl85GQ5pTJ_8jJ6eARCLFHjUnOd3EanIZTWRFnow~691e8dea32a4ef950b2fd9e443b1c391

Analysts' recommendations: DexCom, Inc.

13/08	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
04/08	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT
03/08	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT
03/08	Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating	MT
31/07	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says	MT
31/07	Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating	MT
31/07	RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating	MT
31/07	Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating	MT
31/07	Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating	MT
31/07	Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating	MT
31/07	Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating	MT
31/07	Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating	MT
31/07	Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating	MT
31/07	Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating	MT
31/07	Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating	MT
31/07	JPMorgan Adjusts Price Target on DexCom to $82 From $65, Maintains Neutral Rating	MT
31/07	Piper Sandler Adjusts Price Target on DexCom to $95 From $88, Maintains Overweight Rating	MT
31/07	Wells Fargo Adjusts Price Target on DexCom to $90 From $85, Maintains Overweight Rating	MT
31/07	Stifel Adjusts Price Target on DexCom to $95 From $90, Maintains Buy Rating	MT
31/07	Citigroup Adjusts Price Target on DexCom to $88 From $84, Maintains Buy Rating	MT
31/07	Jefferies Adjusts Price Target on DexCom to $115 From $112, Maintains Buy Rating	MT
31/07	BTIG Adjusts Price Target on DexCom to $90 From $80, Maintains Buy Rating	MT
31/07	Raymond James Adjusts Price Target on DexCom to $94 From $91, Maintains Strong Buy Rating	MT
31/07	Analyst recommendations: Apple, Baxter International, Dexcom, Flex, Humana, Stellantis…
28/07	UBS Adjusts Price Target on DexCom to $96 From $95, Maintains Buy Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
DEXCOM, INC.	-	-	-	-
ABBOTT LABORATORIES				+8.81%
MEDTRONIC PLC				+12.22%
CENCORA, INC.				+9.8%
HOYA CORPORATION				+25.58%
BECTON, DICKINSON AND COMPANY				+4.34%
DEXCOM, INC.				+4.94%
MEDLINE INC.				+22.86%
WEST PHARMACEUTICAL SERVICES, INC.				+18.13%
TERUMO CORPORATION				+26.9%
Average				+14.84%
Weighted average by Cap.				+12.30%